Leadart Technologies is a biomedical company based on novel and high-throughput chemical proteomic platform. Leadart Technologies is focused on accelerating industrial and academic therapeutic innovation to improve human life. We are committed to become the industrial leader in the new era of drug and target discovery. The Leadart Technologies team attended the First Oversea Scholar Startup Competition held in Xiaoshan, Zhejiang, China in December, 2016. Over 30 scholars from oversea participated this competition, and Leadart Technologies team won the ‘Best Business Model Award’.